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The role of T)r-139, which is thought o be located at the active site of Thermus thermophk HB8 3-isopropyhnalate dehydrogenase, has been 
investigated by site-specii3c replacement with phenylalanine. The replacement scarcely affected the Michaelis constant (Z&) for 3-isopropylmalate, 
but caused a 13-fold decrease of that for NAD. The catalytic constant (k,,) showed a 14fold decrease. Accordingly, the catalytic efficiency (k,,/&,) 
decreased for 3-isopropyhnalate but not for NAD. The results suggest hat Tyr-139 is involved in the catalytic function through interaction with 
3-isopropylmalate. 
Active site; Catalysis; 3-Isopropyhnalate dehydrogenase 
1. ~TRODU~ION 
3-Isopropylmalate dehydrogenase (IPMDH, EC 
1.1.1.85) is an enzyme in the leucine biosynthetic path- 
way while isocitrate dehydrogenase (ICDH, EC 
1.1.1.42) is a key enzyme of the tricarboxylic acid cycle 
and also plays a role in glutamate biosynthesis. These 
enzymes act on structurally similar substrates, 
HOOC(HO)CHCH(X)COOH, in which X represents 
the CH(CH,), of 3-isopropy~~ate and CH,COOH of 
isocitrate. Both enzymes catalyze a chemically analo- 
gous reaction: dehydrogenation at C2 to form a car- 
bony1 group from a hydroxyl group; and decarboxyla- 
tion at C3. In recent years, the three-dimensional struc- 
ture of Escherichiu coli ICDH [l] and that of Thermus 
thermophilus IPMDH [2] have been determined by X- 
ray crystallography and the structural similarity be- 
tween them has been pointed out [2]. The structure of 
the active site was also determined for E. coli ICHD- 
substrate complex [3], and the residues urrounding the 
substrate, isocitrate, were found to be well conserved in 
IPMDH. Taking the high similarity of primary struc- 
tures between these two dehydrogena~s (-33%) [4] into 
account, they are assumed to have evolved from a com- 
mon ancestral enzyme to obtain their own substrate 
specificities. The reaction mechanisms of the enzymes 
are, thus, considered to be common. In fact, both en- 
zymes catalyze the same stereospecific protonation to 
carbon-3 of the substrates [5,6] and the same stere- 
ospecific hydride transfer; the hydride-accepting site of 
nicotinamide ring of coenzymes has been identified as 
A form (or proR configuration) [7,8]. 
In ICDH, the oxidation of isocitrate is believed to 
occur in two steps. In the first step, isocitrate is oxidized 
to oxalosuccinate by removal of a proton from the hy- 
droxyl oxygen to a base and the transfer of a hydride 
to coenzyme; and, in the second step, the 3-carboxyl 
group of oxalosuccinate is lost as CO, with a large 
acceleration in rate by a factor of 10’ [9,10]. Hurley et 
al. suggested that Tyr-160 and Lys-230’ (primed num- 
ber indicates the residues which belong to the second 
subunit of the enzyme) in E. coli ICDH are linked to the 
3-carboxyl of isocitrate by a hydrogen bond where they 
are favorably positioned to serve as an acid catalyst that 
protonates the C3 atom of the substrate after decarbox- 
ylation [8]. The corresponding residues are conserved in 
all IPMDHs so far reported, including 7: thermophilus 
enzyme (‘Iyr-139 and Lys-185’, respectively). 
In this paper, in order to analyze in detail the reaction 
mechanism of IPMDH based on its three-dimensional 
structure, Tyr-139, one of the candidates for the acid 
catalyst, was studied by site-directed mutagenesis. To 
minimize the conformational perturbation, the residue 
was changed to phenylalanine and the contribution of 
the hydroxyl group on the catalytic reaction was inves- 
tigated. 
2. EXPERIMENTAL 
2.1. Site-directed mutagenesis 
*Corresponding author. Fax: (81) (45) 922 2432. 
Abbreviations: IPMDH, 3-isopropylmalate dehydrogenase; ICDH, 
isocitrate dehydrogenase. 
Site-directed mutagenesis was carried out according to the method 
of Kunkei [l i]. The oligonucleotide used for generating the base sub- 
stitutions was synthesized on an Applied Biosystems DNA synthesizer 
(381A); 5’ GGG Cl-C CCC GAA GAA TAT CCC CCC GGT G 3’. 
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Table I 
Kinetic parameters of wild-type and mutant enzymes 
x, NM) k,, (s-l) kca#&, (s-l - PM-‘) 
3-Isopropylmalate NAD 3-Isopropylmalate NAD 
Wild-type 1.26 40.9 13.4 10.8 0.333 
Tyrl39Fhe 2.06 3.00 0.937 0.455 0.312 
The base substitutions were conf&med by sequencing with the dido- 
oxynucleotide chain-termination method [12]. 
2.2. Enzyme preparation 
The gene containing the directed mutation was cloned into pTD- 
tacN [13] (derivative of pUCll8) and expressed in E. co/i strain 
MVI 190 (d(lac-proAB), thi, supE, d(srl-recA)306::Tn10 (rep), 
F’[aaD36, proA& lacIqlucZAM15]). The purification procedure de- 
scribed previously [14] was used with slight modifications. Over-ex- 
pressing E. coli cells were grown at 37°C for 4 h in 2 x YT medium 
{8 g Bacto tryptone, 5 g Bacto yeast extract, and 2S g NaCl) contain- 
ing 100 &g/ml ampicillin, and after the addition of isopropyl-&o- 
~iogala~oside at a final eon~n~ation of 0.1 mM the cells were 
further grown for 10 h. The e&s collected (5,OQO x g. IO min) were 
resuspended in 10 mM Tris-HCl buffer (PH 7,6) containing 0.5 mM 
EDTA and subjected to sonication with a Braason sonifier BISP. The 
cell debris was removed by ultracentrifugation (100,000 x g, 20 min) 
and the supernatant was heat-treated (70°C, 20 min) to denature most 
of the proteins in the extract. The supematant was subjected to high- 
performance liquid column chromatographies (Butyl-Toyopearl65OS 
and DEAE-Toyopearl65OS Tosoh), 
2.3, Kinetic experiments 
The Michaelis constant (&) and catalytic constant (I& for 3- 
isopropylmalate were determined in steady-state experiments at 6OO”C 
in SO mM ~-2-hydroxyethylpi~~ne-~-2~th~es~onate-Na 
buffer (pfl: 8.0) containing 100 mM KCl, 5.0 mM MgC&, and 5.0 mM 
NAD. The &, for NAD was determined in the presence of 1.0 mM 
3-isopropyhnalate. Initial velocities were determined by monitoring 
the formation of NADH at 340 nm on a Gilford Response spectro- 
photometer. 
3, RESULTS AND DISCUSSION 
The wild-type and mutant enzymes were purified to 
homogeneity as judged by polyacrylamide gel electro- 
phoresis either in the presence or absence of SDS. The 
mutant enzyme was catalytically active and resistant o 
heat treatment at 70°C fur 20 min just like the wild-type 
enzyme (data nut shown), These abservations uggest 
that the overall structure of the enzyme had not been 
disrupted and that the infmence of the mutation was 
local. 
The kinetic parameters of the wild-type and mutant 
enzymes are listed in Table I. The Michaelis constant, 
K,, for 34sopropylmalate was not changed singificantly 
by the replacement, while that fur NAD decreased by 
13-fold. The catalytic constant, kcatt was greatly reduced 
to 7%, indicating that the hydroxyl group of the tyrosine 
residue is important for eficient catalysis. The catalytic 
efficiency represented by k,,/K, is, accordingly, altered 
only for 34sopropylmalate and not for NAD, In conclu- 
sion, as in the case of E. co/i ICDH, Tyr-139 in T. 
thermap~ilw XPMDH is indeed involved in the catalytic 
function through interaction with the substrate. 
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